BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8803483)

  • 1. Detection of recombinant GAD65 and GAD67 antibodies using a simple radioimmunoassay.
    Kawasaki E; Yano M; Abiru N; Akazawa S; Nagataki S
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):61-9. PubMed ID: 8803483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes.
    Falorni A; Grubin CE; Takei I; Shimada A; Kasuga A; Maruyama T; Ozawa Y; Kasatani T; Saruta T; Li L
    Autoimmunity; 1994; 19(2):113-25. PubMed ID: 7772701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
    Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
    Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type.
    Hagopian WA; Karlsen AE; Gottsäter A; Landin-Olsson M; Grubin CE; Sundkvist G; Petersen JS; Boel E; Dyrberg T; Lernmark A
    J Clin Invest; 1993 Jan; 91(1):368-74. PubMed ID: 8423232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel radioimmunoassay using 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies.
    Marcovina SM; Landin-Olsson M; Essen-Möller A; Palmer JP; Lernmark A
    Int J Clin Lab Res; 2000; 30(1):21-6. PubMed ID: 10984128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
    Walikonis JE; Lennon VA
    Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM.
    Grubin CE; Daniels T; Toivola B; Landin-Olsson M; Hagopian WA; Li L; Karlsen AE; Boel E; Michelsen B; Lernmark A
    Diabetologia; 1994 Apr; 37(4):344-50. PubMed ID: 8063033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
    Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T
    Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Persson B; Lernmark A
    J Autoimmun; 2002 Feb; 18(1):49-53. PubMed ID: 11869046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.
    Gambelunghe G; Forini F; Laureti S; Murdolo G; Toraldo G; Santeusanio F; Brunetti P; Sanjeevi CB; Falorni A
    Clin Endocrinol (Oxf); 2000 May; 52(5):565-73. PubMed ID: 10792335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands.
    Falorni A; Ortqvist E; Persson B; Lernmark A
    J Immunol Methods; 1995 Oct; 186(1):89-99. PubMed ID: 7561152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults.
    Falorni A; Calcinaro F
    Ann N Y Acad Sci; 2002 Apr; 958():99-106. PubMed ID: 12021088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
    Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of autoantibodies to the 65-kD isoform of glutamate decarboxylase by radioimmunoassay.
    Lühder F; Woltanski KP; Mauch L; Haubruck H; Kohnert KD; Rjasanowski I; Michaelis D; Ziegler M
    Eur J Endocrinol; 1994 Jun; 130(6):575-80. PubMed ID: 8205257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase.
    Hagopian WA; Michelsen B; Karlsen AE; Larsen F; Moody A; Grubin CE; Rowe R; Petersen J; McEvoy R; Lernmark A
    Diabetes; 1993 Apr; 42(4):631-6. PubMed ID: 8454115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes.
    Lühder F; Schlosser M; Mauch L; Haubruck H; Rjasanowski I; Michaelis D; Kohnert KD; Ziegler M
    Autoimmunity; 1994; 19(2):71-80. PubMed ID: 7772705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin-GAD65 fusion protein.
    Luo D; Rogers CN; Steed JT; Gilliam LK; Hampe CS; Lernmark A
    J Biotechnol; 2004 Jul; 111(1):97-104. PubMed ID: 15196774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.